AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
01 févr. 2024 16h10 HE
|
AVITA Medical
AVITA Medical to announce fourth quarter and full year 2023 financial results on February 22, 2024, at 1:30 p.m. Pacific Time.
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
10 janv. 2024 16h01 HE
|
AVITA Medical
AVITA Medical announced exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize PermeaDerm in the United States.
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
10 janv. 2024 09h01 HE
|
AVITA Medical
AVITA Medical announced preliminary unaudited financial highlights for the fourth quarter 2023, 2024 financial guidance, and full enrollment of TONE.
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 janv. 2024 09h00 HE
|
AVITA Medical
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.
AVITA Medical to Host Investor Webinar Briefing
04 déc. 2023 09h00 HE
|
AVITA Medical
AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
21 nov. 2023 16h15 HE
|
AVITA Medical
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Updates Full Year 2023 Guidance
20 nov. 2023 16h15 HE
|
AVITA Medical
VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
09 nov. 2023 16h01 HE
|
AVITA Medical
VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
09 nov. 2023 09h00 HE
|
AVITA Medical
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.
AVITA Medical to Announce Third Quarter 2023 Financial Results
19 oct. 2023 16h05 HE
|
AVITA Medical
VALENCIA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...